MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE

被引：0

作者：

Ly, Ina ^{[1
]}

Cardona, Jonathan ^{[2
]}

Beers, Andrew ^{[2
]}

Chang, Ken ^{[2
]}

Brown, James ^{[2
]}

Reardon, David ^{[3
]}

Arrillaga-Romany, Isabel ^{[4
]}

Dietrich, Jorg ^{[1
]}

Forst, Deborah ^{[1
]}

Lee, Eudocia ^{[3
]}

Jordan, Justin ^{[5
]}

Nayak, Lakshmi ^{[3
]}

Wen, Patrick ^{[6
]}

Batchelor, Tracy ^{[4
]}

Kalpathy-Cramer, Jayashree ^{[7
]}

Gerstner, Elizabeth ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA

[5] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-68

引用

页码：191 / 191

页数：1